Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.

Journal of medical genetics - 1 Aug 2021

Wedderburn Sarah, Archer Stephanie, Tischkowitz Marc, Hanson Helen

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Counseling
Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 33568439
DOI: 10.1136/jmedgenet-2020-107529
PMCID: PMC8327314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.PMID 33568439Read ↗

Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanySemantic proximity Read ↗

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read ↗

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionSemantic proximity Read ↗

Clinical genetics in breast cancer.Semantic proximity Read ↗

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesSemantic proximity Read ↗

[European guidelines for health care in hereditary breast cancer].Semantic proximity Read ↗

Breast cancer multigene germline panel testing in mainstream oncology based on clinical-public health utility (cancer mortality benefit): ESMO Precision Oncology Working Group recommendationsSemantic proximity Read ↗

Hereditary breast cancer syndromes and genetic testingSemantic proximity Read ↗

Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?Semantic proximity Read ↗

Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.Semantic proximity Read ↗

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read ↗

Management of Cancer Genetic Testing: A Brief Overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.